Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Abeona Therapeutics to Present at Upcoming Investor Conferences
-
Crinetics Pharmaceuticals to Participate in September Investor Conferences
-
Agile Therapeutics to Participate in Upcoming Investor Conferences
-
Crinetics Pharmaceuticals to Participate in September Investor Conferences
-
Galera to Present at Three Upcoming Investor Conferences in September
-
Galera to Present at Three Upcoming Investor Conferences in September
-
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
-
atai Life Sciences to Participate in Upcoming September Investor Conferences
-
Form SC 13G/A NAVIENT CORP Filed by: Cantor Fitzgerald Europe
-
BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences
-
CohBar to Present at Upcoming Investor Conferences
-
CohBar to Present at Upcoming Investor Conferences
-
Phreesia Inc. (PHR) PT Raised to $70 at Cantor Fitzgerald, Following Earnings
-
9/11 Day Announces Worldwide Television Special In Tribute for 20-Year Remembrance of 9/11 to Air Exclusively on CNN at 7:00 PM ET
-
IPO for SPAC Insight Acquisition Corp. (INAQ) Opens at $9.85
-
Delcath Systems to Present at Upcoming Virtual Investor Conferences
-
Numinus to Participate in Upcoming Investor Conferences in September 2021
-
Arena Pharmaceuticals to Host Virtual R&D Investor Calls and Participate in Upcoming September Investor Conferences
-
Bolt Biotherapeutics to Participate in Upcoming September Investor Conferences
-
Bolt Biotherapeutics to Participate in Upcoming September Investor Conferences
-
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
-
Rigel to Participate in Three Upcoming Investor Conferences
-
UPDATE: Cantor Fitzgerald Starts Regulus Therapeutics (RGLS) at Overweight
-
DTRT Health Acquisition Corp. (DTRTU) Prices 20M Unit IPO at $10/unit
-
Insight Acquisition Corp (INAQ.U) Prices 24M Unit IPO at $10/unit
-
Ascendis Pharma (ASND) Prices 2.5M ADS Offering at $160/sh
-
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
-
Insight Acquisition Corp. Announces Pricing of $240 Million Initial Public Offering
-
DTRT Health Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering
-
Form 8-K Cantor Fitzgerald Income For: Aug 31
-
Nickel 28 Capital Corp (NKL:CN) (CONXF) PT Lowered to Cdn$1.80 at Cantor Fitzgerald
-
Insmed To Participate in Five September Conferences
-
Akebia Therapeutics Announces September 2021 Investor Conference Schedule
-
INOVIO to Present at Upcoming Investor Conferences in September
-
iTeos Therapeutics to Participate in Upcoming September Investor Conferences
-
Orchard Therapeutics to Present at Multiple Investor Conferences in September 2021
-
iTeos Therapeutics to Participate in Upcoming September Investor Conferences
-
Orchard Therapeutics to Present at Multiple Investor Conferences in September 2021
-
New UK Independent Power Producer Created with Investment from EIG
-
Hexo Corp. (HEXO:CN) (HEXO) PT Raised to Cdn$3.45 at Cantor Fitzgerald
-
UPDATE: Cantor Fitzgerald Starts Redhill Biopharma (RDHL) at Overweight
-
The Flowr Corporation Announces Second Quarter and First Half 2021 Results
-
Cascadia Acquisition Corp. Announces Closing of $150 Million Initial Public Offering
-
Adamas to Present at Upcoming September Investor Conferences
-
Sabina Gold and Silver Corp. (SBB:CN) (SGSVF) PT Lowered to Cdn$3 at Cantor Fitzgerald
-
Four-Person Advisor Team Joins UBS in Santa Barbara, CA
-
Portage Biotech Announces Results for First Quarter of 2022 Fiscal Year
-
I-Mab Announces Upcoming Participation at September Conferences
-
UPDATE: Cantor Fitzgerald Upgrades Columbia Care (CCHWF) to Overweight
-
IPO for SPAC Cascadia Acquisition (CCAI) Opens at $9.87

